Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4362520)

Published in Clin Cancer Res on November 01, 2014

Authors

Benjamin D Hopkins1, Ramon E Parsons2

Author Affiliations

1: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
2: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. Ramon.Parsons@mssm.edu.

Articles cited by this

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 17.36

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell (1998) 13.98

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet (1997) 10.71

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A (1999) 7.88

The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol (2012) 7.32

The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A (1998) 6.98

Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science (1998) 6.62

TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res (1997) 5.92

In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell (2011) 5.19

PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res (2011) 4.80

Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet (1997) 4.39

PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer (2011) 4.37

Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature (2009) 4.21

Subtle variations in Pten dose determine cancer susceptibility. Nat Genet (2010) 4.19

Landscaping the cancer terrain. Science (1998) 2.93

A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science (2013) 2.86

Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science (2004) 2.81

Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet (2001) 2.77

Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science (2009) 2.51

Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. Clin Cancer Res (2003) 2.33

The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res (1998) 2.32

Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet (2004) 2.29

PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. Cancer Discov (2011) 2.14

The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene (1999) 2.07

WWP2 is an E3 ubiquitin ligase for PTEN. Nat Cell Biol (2011) 2.00

Breast cancer--loss of PTEN predicts resistance to treatment. N Engl J Med (2004) 1.91

PTEN level in tumor suppression: how much is too little? Cancer Res (2011) 1.90

Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol (1998) 1.85

The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal (2012) 1.81

Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet (1997) 1.74

The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res (2008) 1.63

PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr Biol (2007) 1.62

PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci U S A (2001) 1.62

Haplo-insufficiency: a driving force in cancer. J Pathol (2010) 1.58

PTEN function: the long and the short of it. Trends Biochem Sci (2014) 1.29

Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum Pathol (1999) 0.96

MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol (2002) 0.95

A unified nomenclature and amino acid numbering for human PTEN. Sci Signal (2014) 0.95

Therapeutic targeting of cancers with loss of PTEN function. Curr Drug Targets (2014) 0.93

PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts. J Neurooncol (2010) 0.86

Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells. J Neuropathol Exp Neurol (1999) 0.84